癌症治疗中的心血管毒性:保护心脏,同时对抗癌症
Amit Manhas1,2, Dipti Tripathi1,3,2, Dilip Thomas1
1Stanford Cardiovascular Institute, Stanford, CA, 94305, USA.
Current cardiology reports
|July 23, 2024
概括
化学疗法等癌症疗法可能会损害心脏. 人类诱导的多能干细胞 (hiPSCs) 提供了预测和个性化治疗心脏毒性的新方法.
科学领域:
- 心脏瘤学 - 心脏瘤学
- 干细胞技术 干细胞技术
- 毒性药物毒性 毒性药物毒性
背景情况:
- 癌症疗法,包括化疗和放射疗法,存在重大心血管风险.
- 心脏瘤学是一个新兴的领域,专注于管理这些与治疗相关的副作用.
- 了解心脏毒性机制对于患者护理至关重要.
研究的目的:
- 审查来自癌症治疗的心血管毒性.
- 探索放射治疗,化疗和向疗法的心脏毒性机制.
- 讨论人类诱导多能干细胞 (hiPSC) 技术用于预测建模.
主要方法:
- 关于癌症治疗心脏毒性的最新研究的综述.
- 分析心血管血统差异化hiPSC技术的进展.
- 在预测性疾病建模和临床试验中探索hiPSC应用.
主要成果:
- 化疗药物,如人环素和激酶抑制剂,会增加心血管疾病的风险.
- hiPSC技术允许准确建模药物诱导的心脏毒性.
- 使用hiPSC的个性化心脏毒性评估显示出针对量身定制的治疗策略的希望.
结论:
- 心脏瘤学结合瘤学和心脏病学,以解决与治疗相关的心血管损伤.
- 虽然hiPSC模型提升了预测能力,但复制成人心脏组织和确保可重复性的挑战仍然存在.
- 对于个性化疗法,需要进一步的研究,以平衡癌症治疗疗效与心血管安全.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


